Product References
Opposing effects of genetic variation in MTCH2 for obesity versus heart failure.
Human molecular genetics
Fischer JA,Monroe TO,Pesce LL,Sawicki KT,Quattrocelli M,Bauer R,Kearns SD,Wolf MJ,Puckelwartz MJ,McNally EM
Sun Jan 01 00:00:00 UTC 2023
APOC1 promotes the progression of osteosarcoma by binding to MTCH2.
Experimental and therapeutic medicine
Li R,He H,He X
Sat Apr 01 00:00:00 UTC 2023
APOC1 promotes the progression of osteosarcoma by binding to MTCH2.
Experimental and therapeutic medicine
Li R,He H,He X
Sat Apr 01 00:00:00 UTC 2023
Serine palmitoyltransferase assembles at ER-mitochondria contact sites.
Life science alliance
Aaltonen MJ,Alecu I,König T,Bennett SA,Shoubridge EA
Tue Feb 01 00:00:00 UTC 2022
Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma.
Molecular medicine (Cambridge, Mass.)
Yuan Q,Yang W,Zhang S,Li T,Zuo M,Zhou X,Li J,Li M,Xia X,Chen M,Liu Y
Thu Jan 28 00:00:00 UTC 2021
Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma.
Molecular medicine (Cambridge, Mass.)
Yuan Q,Yang W,Zhang S,Li T,Zuo M,Zhou X,Li J,Li M,Xia X,Chen M,Liu Y
Thu Jan 28 00:00:00 UTC 2021
Reprogramming of m6A epitranscriptome is crucial for shaping of transcriptome and proteome in response to hypoxia.
RNA biology
Wang YJ,Yang B,Lai Q,Shi JF,Peng JY,Zhang Y,Hu KS,Li YQ,Peng JW,Yang ZZ,Li YT,Pan Y,Koeffler HP,Liao JY,Yin D
Fri Jan 01 00:00:00 UTC 2021
The modified mitochondrial outer membrane carrier MTCH2 links mitochondrial fusion to lipogenesis.
The Journal of cell biology
Labbé K,Mookerjee S,Le Vasseur M,Gibbs E,Lerner C,Nunnari J
Mon Nov 01 00:00:00 UTC 2021
The modified mitochondrial outer membrane carrier MTCH2 links mitochondrial fusion to lipogenesis.
The Journal of cell biology
Labbé K,Mookerjee S,Le Vasseur M,Gibbs E,Lerner C,Nunnari J
Mon Nov 01 00:00:00 UTC 2021
MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m6A-YTHDF1-dependent mechanism.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Jiang Q,Sun B,Liu Q,Cai M,Wu R,Wang F,Yao Y,Wang Y,Wang X
Fri Feb 01 00:00:00 UTC 2019
MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m6A-YTHDF1-dependent mechanism.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Jiang Q,Sun B,Liu Q,Cai M,Wu R,Wang F,Yao Y,Wang Y,Wang X
Fri Feb 01 00:00:00 UTC 2019
Dihydroartemisinin inhibits the viability of cervical cancer cells by upregulating caveolin 1 and mitochondrial carrier homolog 2: Involvement of p53 activation and NAD(P)H:quinone oxidoreductase 1 downregulation.
International journal of molecular medicine
Zhang T,Hu Y,Wang T,Cai P
Sat Jul 01 00:00:00 UTC 2017
Dihydroartemisinin inhibits the viability of cervical cancer cells by upregulating caveolin 1 and mitochondrial carrier homolog 2: Involvement of p53 activation and NAD(P)H:quinone oxidoreductase 1 downregulation.
International journal of molecular medicine
Zhang T,Hu Y,Wang T,Cai P
Sat Jul 01 00:00:00 UTC 2017
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2.
The American journal of pathology
Arigoni M,Barutello G,Riccardo F,Ercole E,Cantarella D,Orso F,Conti L,Lanzardo S,Taverna D,Merighi I,Calogero RA,Cavallo F,Quaglino E
Sat Jun 01 00:00:00 UTC 2013
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2.
The American journal of pathology
Arigoni M,Barutello G,Riccardo F,Ercole E,Cantarella D,Orso F,Conti L,Lanzardo S,Taverna D,Merighi I,Calogero RA,Cavallo F,Quaglino E
Sat Jun 01 00:00:00 UTC 2013